Im Cannabis Corp - Asset Resilience Ratio
Im Cannabis Corp (IMCC) has an Asset Resilience Ratio of 1.11% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Im Cannabis Corp to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2021)
This chart shows how Im Cannabis Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see IMCC total asset value.
Liquid Assets Composition Over Time
This chart breaks down Im Cannabis Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore IMCC long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $3.13 Million | 1.11% |
| Total Liquid Assets | $3.13 Million | 1.11% |
Asset Resilience Insights
- Limited Liquidity: Im Cannabis Corp maintains only 1.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Im Cannabis Corp Industry Peers by Asset Resilience Ratio
Compare Im Cannabis Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.35% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728 |
Drug Manufacturers - Specialty & Generic | 9.66% |
Annual Asset Resilience Ratio for Im Cannabis Corp (2004–2021)
The table below shows the annual Asset Resilience Ratio data for Im Cannabis Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 1.09% | $3.13 Million | $287.39 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $38.12 Million | -- |
| 2005-12-31 | 17.15% | $189.00K | $1.10 Million | -2.45pp |
| 2004-12-31 | 19.59% | $225.00K | $1.15 Million | -- |
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.